05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
The Basics - Representations and warranties insurance (R&W Insurance) protects a party from financi...
Read More >
Transactions by special purpose acquisition companies, or SPACs, exploded in 2020, resulting in a 32...
Read More >
On 28 August 2019 investment advisor Third Point LLC (Third Point) and three funds under its control...
Read More >
Persistent confusion over the Department of Labor’s (DOL) “fluctuating workweek” (FWW) pay method...
Read More >
With effect from 6 April 2020, medium and large organisations in the private sector will become resp...
Read More >
On February 18, 2020, U.S. Citizenship and Immigration Services (USCIS) reached the H-2B cap for the...
Read More >